KMG Capital Partners
VC Fund
Denver, United States
KMG Capital Partners is a principal investment firm and is based in the United States.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries KMG Capital Partners invests in
Stages KMG Capital Partners invests in
Countries KMG Capital Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Javier Vergne-Morell
|
|||
|
Kerry R. Hicks
|
|||
Mats Wahlström
|
|||
|
Mats Wahlström
|
|||
Investment Focus
Industry
- Health Care 3 (50%)
- Biotechnology 3 (50%)
- Medical 2 (33%)
- Mobile 1 (17%)
- Fitness 1 (17%)
Stage
- Series C 2 (33%)
- Seed 1 (17%)
- Series A 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Javier Vergne-Morell
Partner
|
Partner | Total investments: 1 | Find email | |
|
Kerry R. Hicks
CEO
|
CEO | Total investments: 1 | Find email | |
|
Mats Wahlström
Executive Chairman
|
Executive Chairman | Total investments: 0 | Find email | |
|
Mats Wahlström
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Circuit Clinical
|
Circuit Clinical was born from the experiences of a physician conducting clinical research in his busy private practice. From the core belief that patients prefer to learn about clinical research from healthcare providers they trust, came the vision for Circuit Clinical Since 2015 we've built one of the largest Integrated ResearchOrganizations [IRO] in the US. Our focus on physician and participant engagement gives us a distinct advantage with identification of motivated participants through direct HIPAA/FDA-compliant Electronic Medical Record (EMR) review. Coupled with our technology products that enhance the participant and physician experience, Circuit Clinical provides our network of more than 1 million patients, our physicians, and our sponsor partners a new path forward in clinical research. | $2.2M / Seed / Jan 28, 2020 | |
TriSalus Life Sciences
|
Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue. | $15M / Series C / Dec 02, 2015 | |
Bottlenose
|
Bottlenose is a cognitive computing company that makes data analysis easy. By automating machine learning, data mining, and predictive analytics, Bottlenose helps its clients spend more time extracting insights and less time managing data.The company's platform, Nerve Center, makes BI live and interactive. It detects patterns and trends inmassive amounts of rapidly changing data to help customers achieve business awareness and complete insight into what is going on in and around the organization.The company was founded in 2010 and headquartered in Sherman Oaks, California. | $13.5M / Series B / Feb 09, 2015 | |
Coherus Biosciences
|
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, andclinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. | $54.7M / Series C / May 19, 2014 | |
Wildflower Health
|
Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California. | $1.7M / Series A / Dec 09, 2013 | |
FitBionic
|
FitBionic is located in Boulder, Colorado, an international epicenter of health and fitness. We are dedicated to one principle: that amputees deserve whole-person care. We believe in stimulating healthy, active lifestyles, and in offering bionics that feel as comfortable, lively, and functional as their biological equivalents. Since our founding,our R&D has been funded by the National Institutes of Health, and we've demonstrated that it's possible to create high-quality, affordable prosthetic feet that may walk more safely over any terrain, reduce pain and fall risk, and particularly serve the needs of amputees with diabetes. Our first product, the FitBionic Foot, has been demonstrated to allow amputees to walk more efficiently than with carbon fiber feet, and additional early data now points to other benefits as well, including improved overall activity and fitness. Most importantly, the first amputees to use this biomechanically designed walking foot have loved it from the first steps. | $2.2M / Aug 08, 2013 |
Co-Investors
High Country Venture
2 deals together
Buffalo Angel Network
1 deal together
Cambia Health Solutions
1 deal together
ff Venture Capital
1 deal together
HealthTech Capital
1 deal together
Helix Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does KMG Capital Partners invest in?
KMG Capital Partners invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact KMG Capital Partners?
Public channels for KMG Capital Partners include the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KMG Capital Partners?
The team at KMG Capital Partners includes Javier Vergne-Morell (Partner), Kerry R. Hicks (CEO) and Mats Wahlström (Executive Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
